Arcus Biosciences
RCUS
RCUS
75 hedge funds and large institutions have $274M invested in Arcus Biosciences in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 34 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 75 → 75 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
Holders
75
Holding in Top 10
4
Calls
$13K
Puts
–
Top Buyers
| 1 | +$13.9M | |
| 2 | +$1.22M | |
| 3 | +$1.08M | |
| 4 |
Two Sigma Investments
New York
|
+$930K |
| 5 |
AG
Algert Global
San Francisco,
California
|
+$871K |
Top Sellers
| 1 | -$23.1M | |
| 2 | -$2.07M | |
| 3 | -$434K | |
| 4 |
Millennium Management
New York
|
-$379K |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$335K |